Effectiveness of gabexate mesilate in acute pancreatitis ... | 合法藥品大搜索

Read More

由 M Büchler 著作 · 1993 · 被引用 286 次 — molecular weight protease inhibitor gabexate mesilate on mortality and complications associated with moder- ate and severe acute pancreatitis. Methods​: Two. Read More

由 SC Kim 著作 · 2013 · 被引用 12 次 — Gabexate mesilate is a synthetic serine protease inhibitor used to prevent or treat acute pancreatitis in adult patients. The purpose of this study ... Read More

由 J Freise 著作 · 1986 · 被引用 34 次 — [Gabexate mesilate in the treatment of acute pancreatitis. Results of a Hannover multicenter double-blind study with 50 patients]. Z Gastroenterol. 1986 Apr ... Read More

由 P Pederzoli 著作 · 1995 · 被引用 8 次 — ... the use of Aprotinin (A) in the treatment of acute pancreatitis (AP) is still widespread in our country. Compared to A, Gabexate Mesilate (FOY) should have the ... Read More

由 M Büchler 著作 · 1993 · 被引用 286 次 — The results show that gabexate mesilate was not effective in preventing complications and mortality in acute pancreatitis. Read More

由 T Seta 著作 · 2014 · 被引用 43 次 — Two trials reported that protease inhibitors (aprotinin [31] and gabexate mesilate [​49]) were effective in preventing abdominal pain [31, 49]. Read More

由 A Messori 著作 · 1995 · 被引用 120 次 — Since the effectiveness of gabexate mesilate in patients with acute pancreatitis is controversial, a metaanalysis of the published literature was conducted. Read More

In the Japanese guidelines, the continuous infusion of high doses of gabexate mesilate does not affect mortality, but significantly reduces the incidence of ... Read More